Table 5 Scenario analysis
Strategy | Cost (USD) | QALYs | \(\Delta \mathrm{ C}\) | \(\Delta \mathrm{ QALYs}\) | BNP vs. Standard clinical assessment |
|---|---|---|---|---|---|
Scenario 1: EQ-5D values from Emrani study | |||||
BNP | 1835 | 1.9 | − 541 | 0.12 | Dominant |
Standard clinical assessment | 2376 | 1.78 | |||
Scenario 2: time horizon 10 years | |||||
BNP | 1805 | 2.15 | − 551 | 0.15 | Dominant |
Standard clinical assessment | 2356 | 2 | |||
Scenario 2: time horizon 20 years | |||||
BNP | 1832 | 2.18 | 542 | 0.11 | Dominant |
Standard clinical assessment | 2374 | 2.07 | |||